Stocktoria
FATE THERAPEUTICS INC FATE
FATE THERAPEUTICS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6M | $13.6M | $63.5M | $96.3M | $55.8M | $31.4M | $10.7M | $4.7M | $4.1M | $4.4M |
| R&D expense | $107.8M | $135.0M | $172.6M | $320.5M | $215.5M | $125.6M | $87.8M | $56.0M | $34.4M | $26.5M |
| Operating income | -$147.7M | -$210.3M | -$190.5M | -$308.4M | -$217.0M | -$128.1M | -$100.7M | -$67.1M | -$42.1M | -$32.0M |
| Interest expense | — | — | — | — | $0 | $0 | $1.8M | $1.7M | $1.3M | $1.6M |
| Income tax | $2,000 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Net income | -$136.3M | -$186.3M | -$160.9M | -$281.7M | -$212.2M | -$173.4M | -$98.1M | -$66.6M | -$43.0M | -$33.5M |
| EPS (diluted) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | — | — | — | — |
| Operating cash flow | -$106.1M | -$122.9M | -$132.3M | -$248.2M | -$162.9M | -$39.2M | -$83.2M | -$38.6M | -$36.9M | -$29.8M |
| Free cash flow | -$112.0M | -$123.6M | -$138.4M | -$283.8M | -$213.6M | -$44.2M | -$90.6M | -$41.0M | -$38.6M | -$30.3M |
| Cash & equivalents | $46.6M | $36.1M | $41.9M | $61.3M | $133.6M | $167.3M | $99.8M | $190.5M | $89.0M | $88.6M |
| Total assets | $318.9M | $440.7M | $506.2M | $705.6M | $921.5M | $622.5M | $302.3M | $213.0M | $105.3M | $95.0M |
| Shareholders' equity | $207.2M | $318.7M | $368.4M | $483.9M | $678.8M | $384.4M | $244.8M | $160.5M | $77.2M | $73.2M |
Growth · year-over-year · Revenue CAGR 4.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -51.2% | -78.5% | -34.0% | +72.4% | +77.7% | +194.3% | +125.3% | +15.4% | -6.7% | +81.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.